LARIMAR THERAPEUTICS, INC. (LRMR) Total liabilities 2016–2019
LARIMAR THERAPEUTICS, INC. (LRMR) total liabilities at each fiscal year-end, per SEC filings.
$5.9MFY2019 · since FY2016: $9.9M → $5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | $5.9M | -79.3% |
| FY2018 | $28.5M | +4.4% |
| FY2017 | $27.3M | +175.9% |
| FY2016 | $9.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More LRMR financial trends
LRMR RevenueLRMR Net incomeLRMR Net marginLRMR Gross profitLRMR Gross marginLRMR Operating incomeLRMR Operating marginLRMR Operating cash flowLRMR Free cash flowLRMR Capital expendituresLRMR Return on equityLRMR Stock buybacksLRMR Dividends paidLRMR Total assetsLRMR Shareholders’ equityLRMR overview →